Accumulating evidence suggests a contribution of T cell-derived IL-17, IL-21 and IL-22 cytokines in skin immune homeostasis as well as inflammatory disorders. Here, we analyzed whether the cytokine-producing T lymphocytes could be induced by the different subsets of human skin dendritic cells (DCs), i.e., epidermal Langerhans cells (LCs), dermal CD1c+CD14？ and CD14+ DCs (DDCs). DCs were purified following a 2-day migration from separated epidermal and dermal sheets and co-cultured with allogeneic T cells before cytokine secretion was explored. Results showed that no skin DCs could induce substantial IL-17 production by na？ve CD4+ or CD8+T lymphocytes whereas all of them could induce IL-17 production by memory T cells. In contrast, LCs and CD1c+CD14？DDCs were able to differentiate na？ve CD4+T lymphocytes into IL-22 and IL-21-secreting cells, LCs being the most efficient in this process. Intracellular cytokine staining showed that the majority of IL-21 or IL-22 secreting CD4+T lymphocytes did not co-synthesized IFN-γ, IL-4 or IL-17. IL-21 and IL-22 production were dependent on the B7/CD28 co-stimulatory pathway and ICOS-L expression on skin LCs significantly reduced IL-21 level. Finally, we found that TGF-β strongly down-regulates both IL-21 and IL-22 secretion by allogeneic CD4+ T cells. These results add new knowledge on the functional specialization of human skin DCs and might suggest new targets in the treatment of inflammatory skin disorders.
References
[1]
Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9: 271–296.
[2]
Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, et al. (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18: 767–811.
[3]
Ueno H, Klechevsky E, Morita R, Aspord C, Cao T, et al. (2007) Dendritic cell subsets in health and disease. Immunol Rev 219: 118–142.
Haniffa M, Ginhoux F, Wang X, Bigley V, Abel M, et al. (2009) Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation. J Exp Med 206: 371–385.
[6]
Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, et al. (2008) Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29: 497–510.
[7]
Carreno BM, Collins M (2002) The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 20: 29–53.
[8]
Greenwald RJ, Freeman GJ, Sharpe AH (2005) The B7 family revisited. Annu Rev Immunol 23: 515–548.
[9]
Fife BT, Bluestone JA (2008) Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev 224: 166–182.
[10]
Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27: 485–517.
[11]
Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21: 467–476.
[12]
Liang SC, Tan XY, Luxenberg DP, Karim R, Danussi-Joannopoulos K, et al. (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203: 2271–2279.
[13]
Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, et al. (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14: 282–289.
[14]
Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, et al. (2007) Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445: 648–651.
[15]
Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F (2009) Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 10: 857–863.
[16]
Fujita H, Nograles KE, Kikuchi T, Gonzalez J, Carucci JA, et al. (2009) Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc Natl Acad Sci USA 106: 21795–21800.
[17]
Trifari S, Kaplan CD, Tran EH Crellin NK, Spits H (2009) Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 10: 864–871.
[18]
Nograles E, Zaba LC, Guttman-Yassky E (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 159: 1092–1102.
[19]
King C, Tangye SG, Mackay CR (2008) T follicular helper (TfH) cells in normal and dysregulated immune responses. Annu Rev Immunol 26: 741–766.
[20]
Caruso R, Botti E, Sarra M, Esposito M, Stolfi C, et al. (2009) Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat Med 15(9): 1013–1015.
[21]
Furio L, Briotet I, Journeaux A, Billard H, Peguet-Navarro J (2010) Human Langerhans cells are more efficient than CD14(？)CD1c(+) dermal dendritic cells at priming na？ve CD4(+) T cells. J Invest Dermatol 130: 1345–1354.
[22]
Manel N, Unutmaz D, Littman DR (2008) The differentiation of human Th-17 requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nature Immunol 9: 641–649.
[23]
Duraisingham SS, Hornig J, Gotch F, Patterson S (2009) TLR-stimulated CD34 stem cell-derived human skin-like and monocyte-derived dendritic cells fail to induce Th17 polarization of na？ve T cells but do stimulate Th1 and Th17 memory responses. J Immunol 183: 2242–2251.
[24]
Mathers AR, Janelsins BM, Rubin JP, Tkacheva OA, Shufesky WJ, et al. (2009) Differential capability of human cutaneous dendritic cell subsets to initiate Th17 responses. J Immunol 182: 921–933.
[25]
Aliahmadi E, Gramlich R, Grützkau A, Hizler M, Krüger M, et al. (2009) TLR2-activated human Langerhans cells promote TH17 polarization via IL-1β, TGF-β and IL-23. Eur J Immunol 39: 1221–1230.
[26]
Clark RA (2009) Skin-resident T cells: the ups and downs of on site immunity. J Invest Dermatol 130: 362–70.
[27]
Res PCM, Piskin G, de Boer OJ, van der Loos CM, Teeling P, et al. (2010) Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvment in the pathogenesis of psoriasis. Plos One 5 e14108: 1–11.
[28]
de Jong A, Pena-Cruz V, Cheng T, Clark RA, Van Rhijn I, et al. (2010) CD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire. Nature Immunol 11: 1102–1110.
[29]
Volpe E, Touzot M, Servant N, Marloie-Provost MA, Hupé P, et al. (2009) Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production. Blood 114: 3610–3614.
[30]
Sallusto F, Lanzavecchia A (2009) Human Th17 cells in infection and autoimmunity. Microbes Infect 11: 620–624.
[31]
Bouguermouh S, Fortin G, Baba N, Rubio L, Sarfati M (2009) CD28 co-stimulation down regulates Th17 development. PLoS One 4 e5087: 1–11.
